Antibiotics in Refractory IBD: Not Without Risks but Are the Alternatives Better? Response to Gilmore et al

Affiliations

Comment

Dan Turner. Inflamm Bowel Dis. 2020.

. 2020 Apr 11;26(5):e42.

doi: 10.1093/ibd/izaa039.

¹ Shaare Zedek Medical Center, The Hebrew University of Jerusalem, Jerusalem, Israel.

No abstract available

Comment on

Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial.
Turner D, Bishai J, Reshef L, Abitbol G, Focht G, Marcus D, Ledder O, Lev-Tzion R, Orlanski-Meyer E, Yerushalmi B, Aloi M, Griffiths AM, Albenberg L, Kolho KL, Assa A, Cohen S, Gophna U, Vlamakis H, Lurz E, Levine A. Turner D, et al. Inflamm Bowel Dis. 2020 Oct 23;26(11):1733-1742. doi: 10.1093/ibd/izz298. Inflamm Bowel Dis. 2020. PMID: 31833543 Clinical Trial.
Letter to the Editor: Antibiotic Cocktail for Pediatric Acute Severe Colitis and the Microbiome: The PRASCO Randomized Controlled Trial.
Gilmore R, Choy MC, Li Wai Suen CFD, De Cruz P. Gilmore R, et al. Inflamm Bowel Dis. 2020 Apr 11;26(5):e41. doi: 10.1093/ibd/izaa038. Inflamm Bowel Dis. 2020. PMID: 32095819 No abstract available.